DanDi Bioscience

ENG 다국어페이지
KOR
NEWS

What’s new?

2023-01-13danbio

HLB Science, research agreement with Theranochem to develop anti-cancer drugs

https://www.yna.co.kr/view/AKR20221110075000017?input=1195m  

This post has been translated from the original article dated 11/10/2022.

 

HLB사이언스, 테라노켐과 항암제 개발 연구협약
▲ HLB Science announced on the 10th that it had entered into a research agreement with Theranochem for joint research to discover new anti-cancer drug candidates. Theranochem is a company with small molecule drug synthesis technology and mitochondria-targeting platform synthesis technology. Through this agreement, HLB Science explained that it plans to develop anticancer drugs for various cancer types such as lung cancer and liver cancer, including 'triple-negative breast cancer' for which there is no clear treatment. (Seoul = Yonhap News)

Next

HLB Science, KRP Report (Kiwoom Securities)

Prev

HLB Science. Seeking cooperation for innovative sepsis treatment in 'Bio Europe'